» Articles » PMID: 38182602

Machine Learning in the Parkinson's Disease Smartwatch (PADS) Dataset

Overview
Date 2024 Jan 5
PMID 38182602
Authors
Affiliations
Soon will be listed here.
Abstract

The utilisation of smart devices, such as smartwatches and smartphones, in the field of movement disorders research has gained significant attention. However, the absence of a comprehensive dataset with movement data and clinical annotations, encompassing a wide range of movement disorders including Parkinson's disease (PD) and its differential diagnoses (DD), presents a significant gap. The availability of such a dataset is crucial for the development of reliable machine learning (ML) models on smart devices, enabling the detection of diseases and monitoring of treatment efficacy in a home-based setting. We conducted a three-year cross-sectional study at a large tertiary care hospital. A multi-modal smartphone app integrated electronic questionnaires and smartwatch measures during an interactive assessment designed by neurologists to provoke subtle changes in movement pathologies. We captured over 5000 clinical assessment steps from 504 participants, including PD, DD, and healthy controls (HC). After age-matching, an integrative ML approach combining classical signal processing and advanced deep learning techniques was implemented and cross-validated. The models achieved an average balanced accuracy of 91.16% in the classification PD vs. HC, while PD vs. DD scored 72.42%. The numbers suggest promising performance while distinguishing similar disorders remains challenging. The extensive annotations, including details on demographics, medical history, symptoms, and movement steps, provide a comprehensive database to ML techniques and encourage further investigations into phenotypical biomarkers related to movement disorders.

Citing Articles

Advanced applications in chronic disease monitoring using IoT mobile sensing device data, machine learning algorithms and frame theory: a systematic review.

Liu Y, Wang B Front Public Health. 2025; 13:1510456.

PMID: 40061474 PMC: 11885302. DOI: 10.3389/fpubh.2025.1510456.


Towards Transforming Neurorehabilitation: The Impact of Artificial Intelligence on Diagnosis and Treatment of Neurological Disorders.

Calderone A, Latella D, Bonanno M, Quartarone A, Mojdehdehbaher S, Celesti A Biomedicines. 2024; 12(10).

PMID: 39457727 PMC: 11504847. DOI: 10.3390/biomedicines12102415.

References
1.
Belvisi D, Conte A, Bologna M, Bloise M, Suppa A, Formica A . Re-emergent tremor in Parkinson's disease. Parkinsonism Relat Disord. 2016; 36:41-46. DOI: 10.1016/j.parkreldis.2016.12.012. View

2.
Ray Dorsey E, Omberg L, Waddell E, Adams J, Adams R, Ali M . Deep Phenotyping of Parkinson's Disease. J Parkinsons Dis. 2020; 10(3):855-873. PMC: 7458535. DOI: 10.3233/JPD-202006. View

3.
Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H . Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019. Front Public Health. 2021; 9:776847. PMC: 8688697. DOI: 10.3389/fpubh.2021.776847. View

4.
Mei J, Desrosiers C, Frasnelli J . Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature. Front Aging Neurosci. 2021; 13:633752. PMC: 8134676. DOI: 10.3389/fnagi.2021.633752. View

5.
Bickmann L, Plagwitz L, Varghese J . Post Hoc Sample Size Estimation for Deep Learning Architectures for ECG-Classification. Stud Health Technol Inform. 2023; 302:182-186. DOI: 10.3233/SHTI230099. View